作者

Simon Cohen

合伙人

Read More

Colin McCall

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

Tasmina Goraya, PhD

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Michael Washbrook

高级法律顾问

Read More
作者

Simon Cohen

合伙人

Read More

Colin McCall

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

Tasmina Goraya, PhD

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Michael Washbrook

高级法律顾问

Read More

2019年6月28日

Synapse

This month on Synapse

The Treatment

Written by a team of Taylor Wessing's legal experts, The Treatment is designed to provide a high level overview of some of the most important issues to consider for any life sciences company seeking these opportunities by coming to Europe.

Webinar: Recent legislative developments affecting biologics and biosimilars

Session 2 of our 2019 biosimilars webinars series focuses on key factors decision makers need to be aware of when considering currently pending legislation.

SPC manufacturing waiver for export and stockpiling comes into force

Michael Washbrook provides an overview of the new SPC manufacturing waiver for export and stockpiling that will come into force on 1 July 2019.

No compulsory licence for Sanofi's Praluent in Germany

Dr Anja Lunze explores the decision of the German Federal Supreme Court to refuse Sanofi’s request for a preliminary compulsory licence regarding Amgen’s patent relating to antigen binding proteins against PCSK9.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Synapse - January 2020

2020年1月16日

作者

点击此处了解更多
酒店与休闲

Synapse - December 2019

2019年12月19日

作者

点击此处了解更多
酒店与休闲

Synapse - November 2019

2019年11月26日

作者

点击此处了解更多